# Indaptus Therapeutics, Inc.: Form 8-K, filed Mar 23, 2023

- Company: [Indaptus Therapeutics, Inc.](/companies/indp.md) (CIK 1857044)
- Form: 8-K
- Filed: 2023-03-23
- Accepted by EDGAR: Mar 23, 2023, 08:00 ET
- Period: 2023-03-22
- Accession: 0001493152-23-008636
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1857044/000149315223008636/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1857044/000149315223008636/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1857044/000149315223008636/form8-k.htm

Filed Mar 23, 2023.
Source: SEC EDGAR, the filing index for accession 0001493152-23-008636. Last ingested by Listed: Nov 14, 2026, 21:10 ET. No prices; not investment advice.
